Summary Despite the numerous advances over the last fifty years with regards to anticoagulant therapy, warfarin remains the definitive typical with the long-term avoidance of thromboembolic gatherings in at-hazard people, apart from Those people with acute coronary syndromes, wherein antiplatelets are preferred. Ximelagatran, a prodrug of melagatra